Skip to main content

Table 2 Comparison by functional outcome for patients with intracerebral hemorrhage and ischemic stroke

From: Association between plasma levels of hyaluronic acid and functional outcome in acute stroke patients

  Intracerebral hemorrhage Ischemic stroke
  mRS ≤2* (n = 23) mRS > 2 (n = 20) P mRS ≤2* (n = 82) mRS > 2 (n = 81) P
Age (years) 54.2 ± 12.9 66.8 ± 13.9 0.004 62.6 ± 14.0 68.3 ± 12.4 0.007
Male 15 (65.2) 13 (65) 1.000 64 (78.0) 47 (58.0) 0.007
Body mass index (kg/m2) 25.1 ± 3.1 22.6 ± 3.8 0.023 25.9 ± 3.8 25.5 ± 3.7 0.528
Diabetes mellitus 8 (34.7) 2 (10.0) 0.076 30 (36.6) 37 (45.7) 0.267
Hypertension 21 (91.3) 18 (90.0) 1.000 53 (64.6) 66 (81.5) 0.021
Hyperlipidemia 3 (13.0) 6 (30.0) 0.263 25 (30.5) 28 (34.6) 0.618
Atril fibrillation 1 (4.3) 1 (5.0) 1.000 17 (20.7) 25 (30.9) 0.155
History of stroke 3 (13.0) 4 (20.0) 0.687 10 (12.2) 26 (32.1) 0.002
WBC (103/μl) 10.2 ± 4.4 10.3 ± 2.8 0.860 8.3 ± 2.8 9.3 ± 4.0 0.050
Hemoglobin 14.9 ± 1.3 13.0 ± 4.4 0.057 14.6 ± 3.7 13.9 ± 1.9 0.173
Glucose (mg/dl) 137.3 ± 59.2 113.5 ± 32.3 0.117 145.5 ± 61.9 148.8 ± 55.8 0.723
Creatinine (mg/dl) 1.2 ± 0.7 1.1 ± 0.4 0.492 1.2 ± 1.0 1.3 ± 0.9 0.356
NIHSS 9.7 ± 5.5 17.6 ± 7.6 <0.001 5.1 ± 5.8 13.1 ± 7.4 <0.001
Systolic blood pressure (mmHg) 184.1 ± 44.5 190.1 ± 38.2 0.640 157.9 ± 31.8 160.8 ± 32.7 0.565
HA < 48 hours (ng/ml) 202.7 ± 134.1 310.1 ± 225.9 0.061 195.9 ± 164.0 226.0 ± 242.6 0.356
HA 48 to 72 hours (ng/ml) 271.1 ± 226.8 879.6 ± 1594.7 0.077 206.1 ± 304.2 379.2 ± 698.0 0.053
  1. Values are shown as number (percentage) or mean ± standard deviation. P values in bold indicate statistical significance. HA, hyaluroninc acid; mRS, modified Rankin scale; NIHSS, National Institute of Health Stroke Scale; WBC, white blood cell. *Favorable outcome is mRS ≤2 at 3 months after stroke; unfavorable outcome is mRS > 2 at 3 months after stroke.